American International Group Inc (NYSE:AIG) retreated 4.1 percent after the company reported a drop in its first-quarter operating income due to rising claims costs. American International Group Inc (NYSE:AIG) stock performance was -4.14% in last session and finished the day at $50.54. Traded volume was 21.78million shares in the last session and the average volume of the stock remained 9.33million shares. The beta of the stock remained 1.99. American International Group Inc (NYSE:AIG) insider ownership is %.

Honghua Group (“Honghua” or the “Group”) (Stock Code: 196.HK), a leading global land drilling rig manufacturer, is pleased to announce that the Group entered into a three-year Memorandum of Understanding for Strategic Cooperation Framework (the “MOU”) with General Electric Company (NYSE:GE) (China) on May 5, 2014, and will jointly endeavor to develop the Honghua’s innovative integrated gas power solution for oil and gas field, and actively capture the huge opportunity of the development of conventional and unconventional energy in China. General Electric Company (NYSE:GE) dropped -1.47 percent to $26.19 Tuesday on volume of 25.03million shares. The intra-day range of the stock was $26.19 to $26.53. General Electric Company (NYSE:GE) has a market capitalization of $263.49billion.

Brazilian stocks closed at their highest level since mid-November Tuesday as shares of state-run energy giant Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), surged to a five-month high on hopes that elections this year could reduce political meddling. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR)’s stock on May 6, 2014 reported a increase of 5.08% to the closing price of $15.30. Its fifty two weeks range is $10.20 -$19.65. The total market capitalization recorded $99.79billion. The overall volume in the last trading session was 40.31million shares. In its share capital, PBR has 6.76billion outstanding shares.

Pfizer Inc. (NYSE:PFE) has provided an infographic that sets out the details of its current R&D activities and the benefits of a potential combination with AstraZeneca. “A combined company would bring together powerful and world leading research expertise in key therapeutic areas … in which the world class academic research resources in the ‘golden triangle’ of Oxford, Cambridge and London would represent a vital component,” said Pfizer Inc. (NYSE:PFE) CEO and chairman Ian Reed in the infographic. On Tuesday, shares of Pfizer Inc. (NYSE:PFE) dropped -1.77% to close the day at $29.43. Company return on investment (ROI) is 10.50% and its monthly performance is recorded as -8.49%. Pfizer Inc. (NYSE:PFE) quarterly revenue growth is -5.61%.